宏利(00945.HK) 今日(7日)宣布与中大医院加强策略性合作伙伴关系，为客户提供更全面的优质康健服务方案。宏利将组织碎化技术这创新疗法，纳入其为确诊癌症或怀疑患上癌症的宏利指定医疗保险计划客户而设的全方位“医护专员支援服务”内。此服务需待组织碎化技术可于中大医院予公众使用后才开始推行，届时有关病人将需参与临床试验，以便密切监测和评估临床结果。
宏利于2021年与中大医院建立了策略性合作伙伴关系，为合资格客户提供一次免费个人医疗咨询。其后于2023年，双方进一步扩展合作关系，宏利就该院所提供的超过300个全包式医疗套餐，包括内视镜检查程序及手术程序，提供免找数预先批核服务。(ha/u)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.